Henry Schein FY2024 EPS Forecast Reduced by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of Henry Schein in a research note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $4.74 per share for the year, down from their prior estimate of $4.81. The consensus estimate for Henry Schein’s current full-year earnings is $4.78 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2024 earnings at $1.19 EPS, Q1 2025 earnings at $1.19 EPS, Q2 2025 earnings at $1.24 EPS, Q3 2025 earnings at $1.25 EPS, Q4 2025 earnings at $1.32 EPS, FY2025 earnings at $5.00 EPS, FY2026 earnings at $5.57 EPS and FY2027 earnings at $6.19 EPS.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the prior year, the firm posted $1.32 earnings per share. The business’s quarterly revenue was up .4% compared to the same quarter last year.

Other equities research analysts have also recently issued research reports about the company. Mizuho began coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. Barrington Research boosted their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Thursday. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Jefferies Financial Group lifted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Seven equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $80.10.

Henry Schein Stock Performance

Henry Schein stock opened at $80.03 on Thursday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.98 billion, a P/E ratio of 32.93, a P/E/G ratio of 2.04 and a beta of 0.89. Henry Schein has a 1-year low of $63.67 and a 1-year high of $82.63. The firm has a 50-day moving average of $73.31 and a 200-day moving average of $71.34.

Insider Activity at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.14% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Henry Schein

Several institutional investors and hedge funds have recently added to or reduced their stakes in HSIC. Cromwell Holdings LLC boosted its holdings in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the last quarter. Versant Capital Management Inc grew its position in shares of Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after acquiring an additional 335 shares during the period. Quent Capital LLC increased its stake in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares in the last quarter. City State Bank bought a new position in Henry Schein in the 4th quarter worth $55,000. Finally, Farther Finance Advisors LLC lifted its position in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.